Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Urowitz

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
The Journal of Rheumatology|November 17, 2015
Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus ErythematosusAmanda J Steiman, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|March 3, 2011
Thrombovascular events affect quality of life in patients with systemic lupus erythematosusAmaris K Balitsky, Valentina Peeva, Jiandong Su, et al.
The Journal of Rheumatology|August 3, 2018
Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in CanadaStephanie O Keeling, Asvina Bissonauth, Sasha Bernatsky, et al.
The Journal of Rheumatology|December 17, 2011
Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosusDarryl Huang, Elaheh Aghdassi, Jiandong Su, et al.
Nature Reviews. Disease Primers|June 17, 2016
Systemic lupus erythematosusArvind Kaul, Caroline Gordon, Mary K Crow, et al.
The Journal of Rheumatology|April 3, 2020
Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic CohortMurray B Urowitz, Dafna D Gladman, Dominique Ibañez, et al.
Lupus Science & Medicine|October 14, 2020
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal studyMurray B Urowitz, Robert L Ohsfeldt, Ronald C Wielage, et al.
Lupus Science & Medicine|May 28, 2021
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosusJagan Sivakumaran, Paula Harvey, Ahmed Omar, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 8, 2011
Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot studyElaheh Aghdassi, David W L Ma, Stacey Morrison, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
The Journal of Rheumatology|November 17, 2015
Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus ErythematosusAmanda J Steiman, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|March 3, 2011
Thrombovascular events affect quality of life in patients with systemic lupus erythematosusAmaris K Balitsky, Valentina Peeva, Jiandong Su, et al.
The Journal of Rheumatology|August 3, 2018
Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in CanadaStephanie O Keeling, Asvina Bissonauth, Sasha Bernatsky, et al.
The Journal of Rheumatology|December 17, 2011
Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosusDarryl Huang, Elaheh Aghdassi, Jiandong Su, et al.
Nature Reviews. Disease Primers|June 17, 2016
Systemic lupus erythematosusArvind Kaul, Caroline Gordon, Mary K Crow, et al.
The Journal of Rheumatology|April 3, 2020
Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic CohortMurray B Urowitz, Dafna D Gladman, Dominique Ibañez, et al.
Lupus Science & Medicine|October 14, 2020
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal studyMurray B Urowitz, Robert L Ohsfeldt, Ronald C Wielage, et al.
Lupus Science & Medicine|May 28, 2021
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosusJagan Sivakumaran, Paula Harvey, Ahmed Omar, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 30, 2008
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosusAntonio Orlacchio, Ian N Bruce, Proton Rahman, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 8, 2011
Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot studyElaheh Aghdassi, David W L Ma, Stacey Morrison, et al.
Pageof 19